Submissions from 2019
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)., Danae Bixler, Yuna Zhong, Kathleen N Ly, Anne C Moorman, Philip R Spradling, Eyasu H Teshale, Loralee B. Rupp, Stuart C. Gordon, Joseph A Boscarino, Mark A Schmidt, Yihe G Daida, and Scott D Holmberg
Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience., Yao-Wen Cheng, Emmalee Phelps, Vincent Ganapini, Noor Khan, Fangqian Ouyang, Huiping Xu, Sahil Khanna, Raseen Tariq, Rachel J Friedman-Moraco, Michael H Woodworth, Tanvi Dhere, Colleen S Kraft, Dina Kao, Justin Smith, Lien Le, Najwa El-Nachef, Nirmal Kaur, Sree Kowsika, Adam Ehrlich, Michael Smith, Nasia Safdar, Elizabeth Ann Misch, Jessica R Allegretti, Ann Flynn, Zain Kassam, Asif Sharfuddin, Raj Vuppalanchi, and Monika Fischer
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States., Stuart C Gordon, Sheri Trudeau, Jia Li, Yueren Zhou, Loralee B Rupp, Scott D Holmberg, Anne C Moorman, Philip R Spradling, Eyasu H Teshale, Joseph A Boscarino, Yihe G Daida, Mark A Schmidt, and Mei Lu
Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection., Eric Lawitz, Fred Poordad, Leah J Anderson, Michelle Vesay, Michelle M Kelly, Hong Liu, Wei Gao, Doreen Fernsler, Ernest Asante-Appiah, Michael N Robertson, George J Hanna, Eliav Barr, Joan Butterton, Kris V Kowdley, Tarek Hassanein, Amandeep Sahota, Stuart C Gordon, and Wendy W Yeh
Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection., Eric Lawitz, Fred Poordad, Leah J Anderson, Michelle Vesay, Michelle M Kelly, Hong Liu, Wei Gao, Doreen Fernsler, Ernest Asante-Appiah, Michael N Robertson, George J Hanna, Eliav Barr, Joan Butterton, Kris V Kowdley, Tarek Hassanein, Amandeep Sahota, Stuart C Gordon, and Wendy W Yeh
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes., Jia Li, Stuart C Gordon, Loralee B Rupp, Talan Zhang, Sheri Trudeau, Scott D Holmberg, Anne C Moorman, Philip R Spradling, Eyasu H Teshale, Joseph A Boscarino, Mark A Schmidt, Yihe G Daida, and Mei Lu
Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B., Mindie H Nguyen, A Burak Ozbay, Iris Liou, Nicole Meyer, Stuart C Gordon, Geoffrey Dusheiko, and Joseph K Lim
Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B., Mindie H Nguyen, Joseph K Lim, A Burak Ozbay, Jeremy Fraysse, Iris Liou, Nicole Meyer, Geoffrey Dusheiko, and Stuart C Gordon
Performance characteristics of EUS-FNA biopsy for adrenal lesions: A meta-analysis., Suhag Patel, Raxitkumar Jinjuvadia, Anupama Devara, Paul H Naylor, Mohammad Anees, Kartikkumar Jinjuvadia, and Mohammad Al-Haddad
Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees., Sachin Wani, Samuel Han, Violette Simon, Matthew Hall, Dayna Early, Eva Aagaard, Wasif M Abidi, Subhas Banerjee, Todd H Baron, Michael Bartel, Erik Bowman, Brian C Brauer, Jonathan M Buscaglia, Linda Carlin, Amitabh Chak, Hemant Chatrath, Abhishek Choudhary, Bradley Confer, Gregory A Coté, Koushik K Das, Christopher J DiMaio, Andrew M Dries, Steven A Edmundowicz, Abdul Hamid El Chafic, Ihab El Hajj, Swan Ellert, Jason Ferreira, Anthony Gamboa, Ian S Gan, Lisa Gangarosa, Bhargava Gannavarapu, Stuart R Gordon, Nalini M Guda, Hazem T Hammad, Cynthia Harris, Sujai Jalaj, Paul Jowell, Sana Kenshil, Jason Klapman, Michael L Kochman, Sri Komanduri, Gabriel Lang, Linda S Lee, David E Loren, Frank Lukens, Daniel Mullady, Raman V Muthusamy, Andrew S Nett, Mojtaba S Olyaee, Kavous Pakseresht, Pranith Perera, Patrick Pfau, Cyrus Piraka, John M Poneros, Amit Rastogi, Anthony Razzak, Brian Riff, Shreyas Saligram, James M Scheiman, Isaiah Schuster, Raj J Shah, Rishi Sharma, Joshua P Spaete, Ajaypal Singh, Muhammad Sohail, Jayaprakash Sreenarasimhaiah, Tyler Stevens, James H Tabibian, Demetrios Tzimas, Dushant S Uppal, Shiro Urayama, Domenico Vitterbo, Andrew Y Wang, Wahid Wassef, Patrick Yachimski, Sergio Zepeda-Gomez, Tobias Zuchelli, and Rajesh N Keswani
Repair of upper-GI fistulas and anastomotic leakage by the use of endoluminal vacuum-assisted closure., Andrew Watson and Tobias Zuchelli
Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection., David Wyles, Ola Weiland, Betty Yao, Frank Weilert, Jean-Francois Dufour, Stuart C Gordon, Albrecht Stoehr, Ashley Brown, Stefan Mauss, Zhenzhen Zhang, Tami Pilot-Matias, Lino Rodrigues, Federico J Mensa, and Fred Poordad
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C., Zobair M Younossi, Maria Stepanova, Rajender Reddy, Michael P Manns, Marc Bourliere, Stuart C Gordon, Eugene Schiff, Tram Tran, Issah Younossi, and Andrei Racila
Submissions from 2018
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA., J Chhatwal, Q Chen, T Ayer, E D Bethea, F Kanwal, K V Kowdley, X Wang, M S Roberts, and Stuart C Gordon
Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States., Raxitkumar Jinjuvadia, Chetna Jinjuvadia, Pimpitcha Puangsricharoen, Naga Chalasani, David W Crabb, and Suthat Liangpunsakul
Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States., Anne C Moorman, Jian Xing, Loralee B Rupp, Stuart C Gordon, Philip R Spradling, Joseph A Boscarino, Mark A Schmidt, Yihe G Daida, Eyasu H Teshale, and Scott D Holmberg
